etoposide has been researched along with MODS in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brioschi, PR; Fumagalli, R; Lippi, MG; Lovisari, F; Terzi, V | 1 |
| Aurer, I; Bašić-Kinda, S; Grah, JJ; Ilić, I; Radman, I | 1 |
| Imamura, Y | 1 |
| Aumont, C; Coppo, P; Fardet, L; Galicier, L; Lambotte, O; Marzac, C; Rivière, S | 1 |
| Allendorf, DJ; Bordoni, RE; Dixon, PM; Grant, SC; Jerome, ML; Miley, DK; Reddy, VB; Robert, F; Saleh, MN; Singh, KP | 1 |
| Rosen, D; Sinno, MG; Wittler, R | 1 |
| Aziz, A; Gosbell, IB; Sanghavi, R; Varghese, B | 1 |
| Asensio Vegas, A; Balandín Moreno, B; Cantos López de Ibargüen, B; Cuiñas León, K; Martínez Arrieta, F; Múñez Rubio, E; Ramos Martínez, A; Romero Pizarro, Y; Sánchez Romero, I | 1 |
| Bayrakci, B; Carcillo, JA; Citak, A; Demirkol, D; Dursun, O; Erkek, N; Gedik, H; Karabocuoglu, M; Karapinar, B; Kendirli, T; Kesici, S; Koroglu, TF; Yildizdas, D | 1 |
| Agazzi, A; Bertolini, F; Calabrese, L; Cinieri, S; Cocquio, A; Goldhirsch, A; Laszlo, D; Martinelli, G; Pruneri, G; Rabascio, C | 1 |
| Ejiri, M; Hara, S; Harima, A; Nakaseko, C; Nishimura, M; Saito, Y; Uehara, T; Yokota, A | 1 |
| Adjei, AA; Creagan, ET; Croghan, G; Frytak, S; Giordano, KF; Jatoi, A; Jett, JR; Marks, R; Molina, J; Okuno, S; Richardson, RL | 1 |
| Carr, TJ; Costanzo, MR; Fisher, RI; Mullen, GM; Swinnen, LJ | 1 |
| Beyer, J; Kingreen, D; Lenz, K; Rick, O; Siegert, W; Weinknecht, S | 1 |
| Becker, AT; Gruppo, RA; Harris, RE; Hashmi, R; Morris, CL; Morris, JD; Sambrano, JE | 1 |
| Kardos, G; van der Deure, J; von Blomberg-van der Flier, BM | 1 |
| Baker, D; Coccia, P; Cramer, LD; Dunkel, IJ; Finlay, JL; Garvin, J; Goldman, S; Kaplan, AM; Klemperer, M; Kramer, E; Packer, RJ; Papadakis, V; Papadopoulos, E; Strandjord, S; Willoughby, M | 1 |
| Hsia, SH; Hsueh, C; Hung, IJ; Jaing, TH; Kao, CC; Tain, YL | 1 |
| Castellino, SM; DeVoe, M; Kalwinsky, D; Powers, R | 1 |
2 review(s) available for etoposide and MODS
| Article | Year |
|---|---|
[Hemophagocytic lymphohistiocytosis].
Topics: Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Disease Progression; Doxorubicin; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Methotrexate; Multiple Organ Failure; Prednisolone; Prednisone; Rituximab; Severity of Illness Index; Transplantation Conditioning; Vidarabine; Vincristine | 2014 |
[Clostridium difficile enteritis].
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clostridioides difficile; Combined Modality Therapy; Enteritis; Enterocolitis, Pseudomembranous; Etoposide; Gastrostomy; Humans; Ileostomy; Intestinal Obstruction; Male; Multiple Organ Failure; Neoplasms, Germ Cell and Embryonal; Nephrectomy; Opportunistic Infections; Orchiectomy; Postoperative Complications; Spain; Superinfection; Testicular Neoplasms | 2011 |
2 trial(s) available for etoposide and MODS
| Article | Year |
|---|---|
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Biomarkers, Tumor; Brain Diseases, Metabolic; Camptothecin; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Endonucleases; Etoposide; Fatigue; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Mitosis; Multiple Organ Failure; Pneumonia; Treatment Outcome; Weight Loss | 2015 |
Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Multiple Organ Failure; Renal Dialysis; Retroperitoneal Neoplasms; Salvage Therapy; Survival Analysis; Testicular Neoplasms; Treatment Outcome | 1997 |
15 other study(ies) available for etoposide and MODS
| Article | Year |
|---|---|
Hemophagocytic lymphohistiocytosis complicated by multiorgan failure: A case report.
Topics: Adult; Dexamethasone; Diagnosis, Differential; Drug Therapy, Combination; Etoposide; Female; Glucocorticoids; Humans; Lymphohistiocytosis, Hemophagocytic; Multiple Organ Failure; Topoisomerase II Inhibitors | 2017 |
Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, AIDS-Related; Male; Multiple Organ Failure; Prednisone; Treatment Failure; Vincristine | 2014 |
Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Aspartate Aminotransferases; Bilirubin; C-Reactive Protein; Etoposide; Female; Ferritins; Fever; France; Glucocorticoids; Hemoglobins; Humans; Immunocompromised Host; L-Lactate Dehydrogenase; Leukocyte Count; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Middle Aged; Multiple Organ Failure; Platelet Count; Retrospective Studies; Sodium; Triglycerides | 2014 |
Concomitant Presentation of Hemophagocytic Lymphohistiocytosis and Posttransplant Lymphoproliferative Disease-Like Lymphoma in a Mildly Immunosuppressed Leukemia Patient: An Unusual Association.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Immunocompromised Host; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Mercaptopurine; Methotrexate; Multiple Organ Failure; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rituximab; Treatment Failure; Vincristine; Viral Load | 2016 |
Toxic shock syndrome caused by hospital-acquired methicillin-resistant Staphylococcus aureus in a patient with pancytopenia.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cross Infection; Cytarabine; Etoposide; Fatal Outcome; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Methicillin-Resistant Staphylococcus aureus; Multiple Organ Failure; Pancytopenia; Shock, Septic; Staphylococcal Infections | 2010 |
Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Combined Modality Therapy; Critical Illness; Cyclosporine; Dexamethasone; Etoposide; Female; Ferritins; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Iron Overload; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Male; Multiple Organ Failure; Plasma Exchange; Prednisolone; Regression Analysis; Sepsis; Survival Rate; Treatment Outcome; Turkey | 2012 |
Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Case Management; Cytarabine; Daunorubicin; Etoposide; Female; Hemoglobins; Hemorrhage; Humans; Jehovah's Witnesses; Leukemia; Male; Middle Aged; Multiple Organ Failure; Patient Acceptance of Health Care; Refusal to Treat; Remission Induction; Tretinoin; Vincristine | 2004 |
Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
Topics: Adolescent; B-Lymphocytes; Cell Line, Transformed; Cell Transformation, Viral; Chronic Disease; Cyclosporine; DNA, Viral; Drug Resistance; Epstein-Barr Virus Infections; Etoposide; Female; Hepatitis, Viral, Human; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Multiple Organ Failure; Peripheral Blood Stem Cell Transplantation; T-Lymphocytes, Cytotoxic; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2004 |
Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: contemporary experience from a single institution.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Carboplatin; Carcinoma, Small Cell; Cisplatin; Creatinine; Cyclophosphamide; Decision Making; Etoposide; Female; Humans; Lung Neoplasms; Male; Medical Records; Middle Aged; Multiple Organ Failure; Neoplasm Staging; Paclitaxel; Platelet Count; Survival Rate; Treatment Outcome | 2005 |
Aggressive treatment for postcardiac transplant lymphoproliferation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Life Tables; Lymphoproliferative Disorders; Male; Mechlorethamine; Methotrexate; Middle Aged; Multiple Organ Failure; Postoperative Complications; Prednisone; Procarbazine; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation.
Topics: Adolescent; Adult; Anticoagulants; Antithrombin III; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Infant; Life Tables; Male; Multiple Organ Failure; Neoplasms; Severity of Illness Index; Survival Analysis; Thrombophilia; Transplantation Conditioning; Treatment Outcome | 1997 |
[Hemophagocytic syndrome].
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Blood Cell Count; Bone Marrow Transplantation; Chickenpox; Child, Preschool; Combined Modality Therapy; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Etoposide; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Male; Multiple Organ Failure; Treatment Outcome | 1997 |
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Graft Survival; Hematologic Diseases; Humans; Infant; Kidney Diseases; Lung Diseases; Male; Middle Aged; Multiple Organ Failure; Nervous System Diseases; Survival Rate; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2000 |
Tumor lysis syndrome in an infant with Langerhans cell histiocytosis successfully treated using continuous arteriovenous hemofiltration.
Topics: Acute Kidney Injury; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Blood Transfusion; Combined Modality Therapy; Disease Progression; Etoposide; Fatal Outcome; Female; Fluid Therapy; Hemofiltration; Histiocytosis, Langerhans-Cell; Humans; Infant; L-Lactate Dehydrogenase; Lymph Nodes; Mercaptopurine; Multiple Organ Failure; Neck; Orbital Diseases; Prednisolone; Sodium Bicarbonate; Temporal Bone; Tumor Lysis Syndrome; Uric Acid; Vinblastine; Vincristine | 2001 |
Abdominal rhabdoid tumor presenting as fetal hydrops: a case report.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cesarean Section; Etoposide; Fatal Outcome; Fetal Diseases; Humans; Hydrops Fetalis; Infant, Newborn; Multiple Organ Failure; Rhabdoid Tumor; Ultrasonography, Prenatal | 2001 |